Brief: Creative Medical Technology Holdings Announces World Health Organization Approval Of “Olastrocel”
02/12/2025 14:16
Dec 2 (Reuters) - Creative Medical Technology Holdings Inc CELZ.O: CREATIVE MEDICAL TECHNOLOGY HOLDINGS ANNOUNCES WORLD HEALTH ORGANIZATION APPROVAL OF “OLASTROCEL” AS INN FOR LEAD ALLOGENEIC CELL THERAPY CELZ-201 Source text: ID:nGNX4P52Zt Further company coverage: CELZ.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Creative Medical Technology Holdings
See all newsBrief: Creative Medical Technology Holdings Achieves Second Who Inn Milestone
Brief: Creative Medical Technology Holdings Reaches Major Clinical Inflection Point With Positive Interim Data From Adapt Trial And Celz-201 (Olastrocel) In The Treatment Of Chronic Lower Back Pain
Brief: Creative Medical Technology Receives Approval For Biodefense Burn Pit Initiative
Brief: Creative Medical Technology Completes Enrollment In FDA-Cleared Adapt Trial
Brief: Creative Medical Technology Holdings Announces World Health Organization Approval Of “Olastrocel”